FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> stents

Report: African-Americans appear more at risk from drug-coated stents

Free Newsletter

FierceDrugDelivery is your source for breaking news and insider analysis on the bio/pharmaceutical drug delivery industry. Sign up today to receive your FREE "insiders only" weekly email briefing!



Tools

Scientists at Georgetown University have discovered some disturbing news for African-Americans. They are more likely than other groups to develop life-threatening clots after receiving a drug-coated stent, and researchers are not sure why. Even after taking into account other known risk factors like diabetes, hypertension, and kidney problems, they found that African-Americans still experience a higher rate of thrombosis or clotting. Ron Waksman, lead author of the study--which appears in Circulation: Journal of the American Heart Association--is urging more studies into the genetic differences that could cause this problem. "The bottom line is this is not just because this population is sicker or less compliant, but there is something else there that needs to be explored," Waksman says in a statement. American Heart Association release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceDrugDelivery Email Newsletter:

More stories about stents